Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04608604Not ApplicableCompleted

Mobility in Atypical Parkinsonism: a Trial of Physiotherapy

Role: collaborator

NCT05184270Not ApplicableCompleted

Integration of Auditory, and Deep Brain Stimulation to Enhance Deep Sleep in Parkinson's Disease

Role: collaborator

NCT03641651Not ApplicableCompleted

New Technologies in the Rehabilitation of Chronic Stroke

Role: collaborator

NCT02720341Not ApplicableTerminated

VIT-ARMin Virtual, Intensified and Patient-tailored Robotic Arm Therapy With the Exoskeleton Robot ARMin

Role: collaborator

All 4 trials loaded